Skip to NavigationSkip to content

News

Allergan and Novartis have announced a new partnership to conduct a clinical trial in the treatment area of non-alcoholic steatohepatitis (NASH),...
Hyland has issued an official voluntary recall of its homeopathic teething tablets, with the US regulatory body advising parents to cease any use...
Circassia has slumped at the Phase 2 clinical trial stage again, as its treatment for dust mite allergies was unable to improve on placebo treatment.
Roche’s Genentech has revealed that its immunotherapy drug Tecentriq (atezolizumab) is now enjoying an expanded indication in the US after approval...
New research emerging out of Swansea University could allow the real-time monitoring of wounds for infections and to measure the healing process,...
St Jude Medical has been hit with a warning letter from the FDA over the medical device manufacturer’s failure to address issues with its...
Rebiotix is one a new breed of companies that aims to use the human body’s microbiome to treat illnesses and conditions caused by an imbalance within...
Researchers from The Feinstein Institute for Medical Research's Karches Center for Oncology Research has had a research breakthrough by taking a...
Researchers at the University of Surrey have discovered a ‘supermolecule’ which they claim can seek harmful pharmaceuticals from water in an...
Researchers have tested to see whether Marmite, with its high levels of vitamin B12, may be beneficial for brain health, in a trial that analysed...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches